United States · FDA National Drug Code directory
Ruxience
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0069-0238_1f47d28b-1604-4e95-a668-46d81e4b5b27
- Product NDC
- 0069-0238
- Form
- INJECTION, SOLUTION
- Composition / generic term
- rituximab-pvvr
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Marketing category
- BLA
- Marketing start / end (source format)
- 20200123
- Source listing expiry
- 20271231
Source-listed ingredients
- RITUXIMAB — 100 mg/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (0069-0238-01) / 10 mL in 1 VIAL, SINGLE-USE · 0069-0238-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →